Motif ID: Foxi1_Foxo1
Z-value: 2.304
Transcription factors associated with Foxi1_Foxo1:
Gene Symbol | Entrez ID | Gene Name |
---|---|---|
Foxi1 | ENSMUSG00000047861.2 | Foxi1 |
Foxo1 | ENSMUSG00000044167.5 | Foxo1 |
Activity-expression correlation:
Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Foxo1 | mm10_v2_chr3_+_52268337_52268388 | 0.08 | 5.4e-01 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
11.7 | 70.2 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
10.0 | 50.2 | GO:0015671 | oxygen transport(GO:0015671) |
9.3 | 28.0 | GO:0021759 | globus pallidus development(GO:0021759) |
7.1 | 21.3 | GO:0045819 | positive regulation of glycogen catabolic process(GO:0045819) |
6.5 | 19.5 | GO:0045659 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
5.7 | 17.2 | GO:0048014 | Tie signaling pathway(GO:0048014) |
5.7 | 17.1 | GO:0021557 | oculomotor nerve development(GO:0021557) ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
5.5 | 49.7 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
5.2 | 15.5 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
5.1 | 10.3 | GO:0010957 | negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
4.6 | 13.9 | GO:0072076 | nephrogenic mesenchyme development(GO:0072076) |
4.6 | 18.5 | GO:0072675 | osteoclast fusion(GO:0072675) |
4.1 | 12.3 | GO:0042908 | xenobiotic transport(GO:0042908) |
4.1 | 53.0 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
3.9 | 74.2 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
3.3 | 16.5 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
3.1 | 12.5 | GO:2001269 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001269) |
3.1 | 9.4 | GO:0042320 | regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) circadian sleep/wake cycle, REM sleep(GO:0042747) positive regulation of circadian sleep/wake cycle, sleep(GO:0045938) |
3.1 | 9.3 | GO:0002053 | positive regulation of mesenchymal cell proliferation(GO:0002053) |
3.1 | 15.3 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
3.1 | 9.2 | GO:0007521 | muscle cell fate determination(GO:0007521) mammary placode formation(GO:0060596) |
3.0 | 17.9 | GO:0071699 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
2.9 | 11.4 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
2.8 | 8.5 | GO:0097274 | urea homeostasis(GO:0097274) |
2.7 | 16.2 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
2.7 | 8.0 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
2.6 | 5.3 | GO:1902219 | regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
2.6 | 10.5 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
2.6 | 13.1 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
2.6 | 10.4 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
2.6 | 10.4 | GO:0002339 | B cell selection(GO:0002339) |
2.5 | 7.6 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
2.5 | 12.4 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
2.4 | 7.3 | GO:0015938 | coenzyme A catabolic process(GO:0015938) nucleoside bisphosphate catabolic process(GO:0033869) ribonucleoside bisphosphate catabolic process(GO:0034031) purine nucleoside bisphosphate catabolic process(GO:0034034) |
2.4 | 7.2 | GO:0001869 | regulation of complement activation, lectin pathway(GO:0001868) negative regulation of complement activation, lectin pathway(GO:0001869) |
2.4 | 7.2 | GO:0036388 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
2.4 | 7.2 | GO:1990034 | calcium ion export from cell(GO:1990034) |
2.3 | 7.0 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
2.3 | 41.7 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
2.3 | 6.9 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
2.3 | 6.8 | GO:0071105 | response to interleukin-11(GO:0071105) |
2.1 | 10.7 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
2.1 | 23.5 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
2.1 | 40.3 | GO:0038092 | nodal signaling pathway(GO:0038092) |
2.1 | 19.0 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
2.1 | 6.3 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
2.1 | 6.3 | GO:0030300 | regulation of intestinal cholesterol absorption(GO:0030300) |
2.1 | 4.2 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
2.1 | 8.3 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
2.1 | 10.4 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
2.1 | 4.1 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
2.1 | 6.2 | GO:0090425 | hepatocyte cell migration(GO:0002194) branching involved in pancreas morphogenesis(GO:0061114) acinar cell differentiation(GO:0090425) positive regulation of forebrain neuron differentiation(GO:2000979) |
2.1 | 12.4 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
2.0 | 10.2 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
2.0 | 6.0 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
2.0 | 21.8 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
2.0 | 7.9 | GO:0010510 | regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) |
2.0 | 9.8 | GO:2000668 | dendritic cell apoptotic process(GO:0097048) regulation of dendritic cell apoptotic process(GO:2000668) |
1.9 | 42.0 | GO:0006270 | DNA replication initiation(GO:0006270) |
1.9 | 5.6 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
1.9 | 5.6 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
1.8 | 9.1 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
1.8 | 3.6 | GO:0014016 | neuroblast differentiation(GO:0014016) |
1.8 | 3.6 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
1.7 | 15.6 | GO:0051574 | positive regulation of histone H3-K9 methylation(GO:0051574) |
1.7 | 5.1 | GO:0035574 | histone H4-K20 demethylation(GO:0035574) |
1.7 | 3.4 | GO:0036292 | DNA rewinding(GO:0036292) |
1.7 | 18.6 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
1.7 | 6.7 | GO:0021698 | cerebellar cortex structural organization(GO:0021698) |
1.7 | 5.0 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
1.6 | 14.7 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
1.6 | 11.3 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
1.6 | 24.1 | GO:2001224 | positive regulation of neuron migration(GO:2001224) |
1.6 | 4.8 | GO:0050904 | diapedesis(GO:0050904) |
1.6 | 7.8 | GO:0070171 | negative regulation of tooth mineralization(GO:0070171) |
1.6 | 17.2 | GO:0021780 | oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
1.5 | 6.2 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
1.5 | 6.1 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
1.5 | 4.5 | GO:0001866 | NK T cell proliferation(GO:0001866) |
1.5 | 7.5 | GO:0002667 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) negative regulation of protein kinase C signaling(GO:0090038) |
1.5 | 4.5 | GO:2000739 | regulation of mesenchymal stem cell differentiation(GO:2000739) |
1.5 | 4.5 | GO:2000832 | protein-chromophore linkage(GO:0018298) negative regulation of steroid hormone secretion(GO:2000832) negative regulation of corticosteroid hormone secretion(GO:2000847) negative regulation of glucocorticoid secretion(GO:2000850) |
1.5 | 4.4 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
1.4 | 4.3 | GO:0060854 | patterning of lymph vessels(GO:0060854) |
1.4 | 7.1 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
1.4 | 7.1 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
1.4 | 7.0 | GO:0031860 | telomeric 3' overhang formation(GO:0031860) |
1.4 | 4.2 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
1.4 | 8.3 | GO:0060836 | lymphatic endothelial cell differentiation(GO:0060836) |
1.4 | 17.7 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
1.4 | 4.1 | GO:0030223 | neutrophil differentiation(GO:0030223) |
1.3 | 5.4 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
1.3 | 8.1 | GO:1903441 | protein localization to ciliary membrane(GO:1903441) |
1.3 | 10.7 | GO:0015670 | carbon dioxide transport(GO:0015670) |
1.3 | 10.7 | GO:0015074 | DNA integration(GO:0015074) |
1.3 | 14.6 | GO:0060539 | diaphragm development(GO:0060539) |
1.3 | 3.9 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
1.3 | 3.9 | GO:0021546 | rhombomere development(GO:0021546) |
1.3 | 6.5 | GO:0072429 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
1.3 | 9.0 | GO:0032264 | IMP salvage(GO:0032264) |
1.3 | 7.7 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
1.3 | 5.1 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
1.3 | 6.3 | GO:1904690 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
1.3 | 17.6 | GO:0051451 | myoblast migration(GO:0051451) |
1.2 | 18.7 | GO:0048642 | negative regulation of skeletal muscle tissue development(GO:0048642) |
1.2 | 8.5 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
1.2 | 12.1 | GO:0046036 | GTP biosynthetic process(GO:0006183) CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
1.2 | 6.0 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
1.2 | 21.4 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
1.2 | 7.0 | GO:0034587 | piRNA metabolic process(GO:0034587) |
1.2 | 3.5 | GO:1902524 | negative regulation of interferon-alpha production(GO:0032687) interferon-alpha biosynthetic process(GO:0045349) regulation of interferon-alpha biosynthetic process(GO:0045354) negative regulation of interferon-beta biosynthetic process(GO:0045358) positive regulation of protein K48-linked ubiquitination(GO:1902524) |
1.2 | 15.1 | GO:0060159 | regulation of dopamine receptor signaling pathway(GO:0060159) |
1.1 | 3.4 | GO:0060681 | branch elongation involved in ureteric bud branching(GO:0060681) |
1.1 | 13.7 | GO:0097154 | GABAergic neuron differentiation(GO:0097154) |
1.1 | 4.5 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
1.1 | 3.4 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
1.1 | 5.6 | GO:0010359 | regulation of anion channel activity(GO:0010359) |
1.1 | 1.1 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
1.1 | 3.3 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
1.1 | 1.1 | GO:2000642 | negative regulation of early endosome to late endosome transport(GO:2000642) |
1.1 | 5.5 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
1.1 | 5.4 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
1.1 | 31.5 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
1.1 | 5.4 | GO:0072539 | T-helper 17 cell differentiation(GO:0072539) |
1.1 | 2.1 | GO:0045409 | negative regulation of interleukin-6 biosynthetic process(GO:0045409) |
1.1 | 2.1 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
1.1 | 5.3 | GO:1902514 | regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1902514) |
1.0 | 4.2 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
1.0 | 5.2 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
1.0 | 24.9 | GO:0007638 | mechanosensory behavior(GO:0007638) |
1.0 | 5.0 | GO:0002553 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
1.0 | 5.0 | GO:0000237 | leptotene(GO:0000237) |
1.0 | 5.0 | GO:0046654 | tetrahydrofolate biosynthetic process(GO:0046654) |
1.0 | 3.0 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
1.0 | 3.0 | GO:1990481 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) snRNA pseudouridine synthesis(GO:0031120) mRNA pseudouridine synthesis(GO:1990481) |
1.0 | 10.9 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
1.0 | 4.8 | GO:0032202 | telomere assembly(GO:0032202) |
1.0 | 13.3 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.9 | 3.8 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.9 | 1.9 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.9 | 2.8 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.9 | 2.8 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.9 | 11.9 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.9 | 3.7 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.9 | 8.8 | GO:0048664 | neuron fate determination(GO:0048664) |
0.9 | 2.6 | GO:1902044 | regulation of Fas signaling pathway(GO:1902044) negative regulation of Fas signaling pathway(GO:1902045) |
0.9 | 3.5 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.9 | 5.2 | GO:0097368 | establishment of Sertoli cell barrier(GO:0097368) |
0.9 | 2.6 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.9 | 5.2 | GO:0098700 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.9 | 2.6 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
0.8 | 4.2 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.8 | 8.4 | GO:0060179 | male mating behavior(GO:0060179) |
0.8 | 4.2 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.8 | 5.8 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.8 | 0.8 | GO:0032240 | negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
0.8 | 4.1 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.8 | 2.4 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
0.8 | 4.0 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.8 | 4.0 | GO:0003383 | apical constriction(GO:0003383) |
0.8 | 4.8 | GO:0045625 | regulation of T-helper 1 cell differentiation(GO:0045625) positive regulation of T-helper 2 cell differentiation(GO:0045630) |
0.8 | 5.5 | GO:0045915 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.8 | 5.5 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.8 | 12.3 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.8 | 3.1 | GO:0060032 | notochord regression(GO:0060032) |
0.8 | 2.3 | GO:0046368 | GDP-L-fucose metabolic process(GO:0046368) |
0.8 | 3.1 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.8 | 4.6 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.8 | 4.5 | GO:0051461 | regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.8 | 1.5 | GO:0045410 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
0.7 | 2.2 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.7 | 3.0 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) negative regulation of respiratory burst(GO:0060268) |
0.7 | 0.7 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.7 | 2.2 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.7 | 8.0 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
0.7 | 2.2 | GO:2000852 | regulation of corticosterone secretion(GO:2000852) |
0.7 | 2.9 | GO:0043973 | histone H3-K4 acetylation(GO:0043973) |
0.7 | 5.0 | GO:0002011 | morphogenesis of an epithelial sheet(GO:0002011) |
0.7 | 3.6 | GO:1904721 | regulation of mRNA cleavage(GO:0031437) negative regulation of mRNA cleavage(GO:0031438) negative regulation of immunoglobulin secretion(GO:0051025) negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904720) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
0.7 | 2.1 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.7 | 2.1 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.7 | 20.7 | GO:0042462 | eye photoreceptor cell development(GO:0042462) |
0.7 | 6.8 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.7 | 2.7 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.6 | 2.6 | GO:0009597 | detection of virus(GO:0009597) |
0.6 | 2.6 | GO:0070425 | negative regulation of nucleotide-binding oligomerization domain containing signaling pathway(GO:0070425) negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070433) |
0.6 | 2.5 | GO:1904714 | chaperone-mediated autophagy(GO:0061684) regulation of chaperone-mediated autophagy(GO:1904714) negative regulation of chaperone-mediated autophagy(GO:1904715) |
0.6 | 3.2 | GO:0019230 | protein autoprocessing(GO:0016540) proprioception(GO:0019230) |
0.6 | 0.6 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) positive regulation of protein complex disassembly(GO:0043243) positive regulation of protein depolymerization(GO:1901881) |
0.6 | 0.6 | GO:0042776 | mitochondrial ATP synthesis coupled proton transport(GO:0042776) |
0.6 | 6.8 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.6 | 1.8 | GO:1902065 | response to L-glutamate(GO:1902065) |
0.6 | 1.2 | GO:0008228 | opsonization(GO:0008228) |
0.6 | 1.8 | GO:0032918 | polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
0.6 | 6.0 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.6 | 1.8 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.6 | 4.7 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.6 | 3.5 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) cellular lipid biosynthetic process(GO:0097384) ether biosynthetic process(GO:1901503) |
0.6 | 12.2 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.6 | 2.3 | GO:0021940 | positive regulation of cerebellar granule cell precursor proliferation(GO:0021940) |
0.6 | 1.1 | GO:0045014 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
0.6 | 9.0 | GO:0042407 | cristae formation(GO:0042407) |
0.6 | 2.8 | GO:0030091 | protein repair(GO:0030091) |
0.6 | 1.7 | GO:0009174 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.5 | 1.6 | GO:0009812 | flavonoid metabolic process(GO:0009812) flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.5 | 12.5 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
0.5 | 2.7 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.5 | 2.1 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.5 | 2.7 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.5 | 2.1 | GO:0033580 | protein glycosylation at cell surface(GO:0033575) protein galactosylation at cell surface(GO:0033580) protein galactosylation(GO:0042125) |
0.5 | 9.3 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.5 | 2.1 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.5 | 1.0 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.5 | 5.1 | GO:0071455 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
0.5 | 2.0 | GO:0048539 | mature ribosome assembly(GO:0042256) bone marrow development(GO:0048539) |
0.5 | 5.1 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.5 | 3.0 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.5 | 0.5 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
0.5 | 1.0 | GO:0035461 | vitamin transmembrane transport(GO:0035461) |
0.5 | 5.5 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
0.5 | 1.0 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.5 | 3.4 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.5 | 1.0 | GO:0030202 | heparin metabolic process(GO:0030202) heparin biosynthetic process(GO:0030210) |
0.5 | 3.4 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
0.5 | 3.4 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.5 | 5.7 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.5 | 2.8 | GO:0006662 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
0.5 | 2.3 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.5 | 17.7 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.5 | 0.9 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.5 | 2.3 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.5 | 3.2 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.5 | 1.4 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.5 | 3.7 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.5 | 0.5 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.5 | 3.6 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.4 | 2.7 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.4 | 3.5 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.4 | 3.5 | GO:0042541 | hemoglobin biosynthetic process(GO:0042541) |
0.4 | 1.3 | GO:0048254 | snoRNA localization(GO:0048254) |
0.4 | 5.2 | GO:0046597 | negative regulation of viral entry into host cell(GO:0046597) |
0.4 | 1.3 | GO:0070269 | pyroptosis(GO:0070269) |
0.4 | 5.1 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.4 | 9.0 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.4 | 9.8 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.4 | 1.7 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.4 | 2.1 | GO:0006573 | valine metabolic process(GO:0006573) |
0.4 | 0.8 | GO:1904139 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
0.4 | 5.0 | GO:0031297 | replication fork processing(GO:0031297) |
0.4 | 0.4 | GO:0002666 | tolerance induction to self antigen(GO:0002513) positive regulation of T cell tolerance induction(GO:0002666) |
0.4 | 4.1 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.4 | 4.5 | GO:0019985 | translesion synthesis(GO:0019985) |
0.4 | 1.6 | GO:0006842 | tricarboxylic acid transport(GO:0006842) succinate transport(GO:0015744) citrate transport(GO:0015746) |
0.4 | 2.0 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.4 | 0.8 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.4 | 1.6 | GO:1901837 | negative regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901837) |
0.4 | 2.0 | GO:0010991 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
0.4 | 2.0 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.4 | 1.2 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.4 | 6.2 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.4 | 3.9 | GO:0071763 | nuclear membrane organization(GO:0071763) |
0.4 | 1.5 | GO:0044828 | negative regulation by host of viral process(GO:0044793) negative regulation by host of viral genome replication(GO:0044828) |
0.4 | 2.3 | GO:0035729 | response to hepatocyte growth factor(GO:0035728) cellular response to hepatocyte growth factor stimulus(GO:0035729) |
0.4 | 4.9 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.4 | 3.0 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.4 | 1.5 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
0.4 | 1.5 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.4 | 1.1 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.4 | 13.0 | GO:0032611 | interleukin-1 beta production(GO:0032611) |
0.4 | 2.9 | GO:0045910 | negative regulation of DNA recombination(GO:0045910) |
0.4 | 4.3 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.4 | 1.8 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.4 | 2.5 | GO:0009162 | nucleoside monophosphate catabolic process(GO:0009125) deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.4 | 3.2 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
0.4 | 6.3 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.4 | 1.8 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.4 | 2.5 | GO:0001711 | endodermal cell fate commitment(GO:0001711) |
0.4 | 1.8 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.4 | 5.6 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.3 | 2.1 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.3 | 6.6 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.3 | 1.7 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.3 | 1.7 | GO:2001054 | negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
0.3 | 1.0 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) positive regulation of natural killer cell degranulation(GO:0043323) |
0.3 | 4.4 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
0.3 | 0.3 | GO:0090400 | stress-induced premature senescence(GO:0090400) |
0.3 | 3.6 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.3 | 1.3 | GO:2000324 | positive regulation of glucocorticoid receptor signaling pathway(GO:2000324) |
0.3 | 1.6 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.3 | 7.4 | GO:0006825 | copper ion transport(GO:0006825) |
0.3 | 2.5 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.3 | 2.9 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.3 | 10.4 | GO:0030071 | regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
0.3 | 8.4 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.3 | 0.3 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.3 | 4.0 | GO:0032402 | melanosome transport(GO:0032402) pigment granule transport(GO:0051904) |
0.3 | 3.7 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.3 | 0.6 | GO:0071499 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
0.3 | 8.5 | GO:0042168 | heme metabolic process(GO:0042168) |
0.3 | 2.4 | GO:0015868 | purine nucleotide transport(GO:0015865) purine ribonucleotide transport(GO:0015868) |
0.3 | 7.5 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
0.3 | 1.2 | GO:0090220 | meiotic telomere clustering(GO:0045141) chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) |
0.3 | 0.6 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.3 | 0.9 | GO:1900225 | NLRP3 inflammasome complex assembly(GO:0044546) regulation of NLRP3 inflammasome complex assembly(GO:1900225) |
0.3 | 1.8 | GO:0001980 | regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) |
0.3 | 1.8 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.3 | 1.8 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.3 | 5.0 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.3 | 1.8 | GO:0009249 | protein lipoylation(GO:0009249) |
0.3 | 1.2 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
0.3 | 1.2 | GO:0060333 | regulation of macrophage fusion(GO:0034239) interferon-gamma-mediated signaling pathway(GO:0060333) |
0.3 | 5.5 | GO:0045907 | positive regulation of vasoconstriction(GO:0045907) |
0.3 | 2.0 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.3 | 4.6 | GO:0032060 | bleb assembly(GO:0032060) |
0.3 | 1.1 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.3 | 4.7 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.3 | 5.8 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.3 | 2.7 | GO:0036035 | osteoclast development(GO:0036035) |
0.3 | 2.7 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.3 | 0.5 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
0.3 | 0.8 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.3 | 1.3 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) response to amino acid starvation(GO:1990928) |
0.3 | 4.8 | GO:0000154 | rRNA modification(GO:0000154) |
0.3 | 1.6 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.3 | 2.6 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.3 | 3.3 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.3 | 2.6 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.3 | 0.3 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
0.3 | 2.5 | GO:0019369 | arachidonic acid metabolic process(GO:0019369) |
0.3 | 3.3 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.3 | 1.8 | GO:0030224 | monocyte differentiation(GO:0030224) |
0.3 | 1.5 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.2 | 2.0 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.2 | 1.0 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.2 | 1.2 | GO:0044346 | fibroblast apoptotic process(GO:0044346) |
0.2 | 0.7 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
0.2 | 8.6 | GO:0051384 | response to glucocorticoid(GO:0051384) |
0.2 | 3.6 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.2 | 8.6 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.2 | 2.1 | GO:0048368 | lateral mesoderm development(GO:0048368) |
0.2 | 1.4 | GO:2001212 | regulation of vasculogenesis(GO:2001212) positive regulation of vasculogenesis(GO:2001214) |
0.2 | 0.5 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.2 | 0.9 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.2 | 2.7 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
0.2 | 1.1 | GO:0061052 | negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
0.2 | 2.0 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.2 | 0.7 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.2 | 13.2 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.2 | 1.3 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.2 | 4.4 | GO:0061028 | establishment of endothelial barrier(GO:0061028) |
0.2 | 1.5 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.2 | 0.6 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.2 | 0.9 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.2 | 1.1 | GO:0061042 | vascular wound healing(GO:0061042) |
0.2 | 1.5 | GO:0050957 | equilibrioception(GO:0050957) |
0.2 | 1.7 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.2 | 1.1 | GO:0048661 | positive regulation of smooth muscle cell proliferation(GO:0048661) |
0.2 | 2.5 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.2 | 1.9 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.2 | 3.1 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.2 | 2.3 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.2 | 1.6 | GO:0019348 | polyprenol metabolic process(GO:0016093) dolichol metabolic process(GO:0019348) |
0.2 | 0.6 | GO:0031590 | wybutosine metabolic process(GO:0031590) wybutosine biosynthetic process(GO:0031591) |
0.2 | 3.0 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.2 | 1.2 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
0.2 | 2.4 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.2 | 1.8 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.2 | 13.9 | GO:0051225 | spindle assembly(GO:0051225) |
0.2 | 0.6 | GO:0019236 | response to pheromone(GO:0019236) |
0.2 | 6.4 | GO:0030901 | midbrain development(GO:0030901) |
0.2 | 0.4 | GO:0035990 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
0.2 | 0.6 | GO:0006301 | postreplication repair(GO:0006301) |
0.2 | 0.8 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.2 | 2.1 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.2 | 2.1 | GO:0032291 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.2 | 1.5 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.2 | 5.4 | GO:0035315 | hair cell differentiation(GO:0035315) |
0.2 | 5.0 | GO:0007052 | mitotic spindle organization(GO:0007052) |
0.2 | 1.1 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.2 | 0.2 | GO:0010455 | positive regulation of cell fate commitment(GO:0010455) |
0.2 | 10.2 | GO:0006261 | DNA-dependent DNA replication(GO:0006261) |
0.2 | 2.5 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.2 | 2.1 | GO:0015781 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.2 | 5.1 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
0.2 | 1.2 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.2 | 0.9 | GO:0006108 | malate metabolic process(GO:0006108) |
0.2 | 0.9 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.2 | 1.5 | GO:0046415 | urate metabolic process(GO:0046415) |
0.2 | 2.0 | GO:0099625 | regulation of ventricular cardiac muscle cell membrane repolarization(GO:0060307) ventricular cardiac muscle cell membrane repolarization(GO:0099625) |
0.2 | 0.8 | GO:0019835 | cytolysis(GO:0019835) |
0.2 | 1.7 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
0.2 | 0.3 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.2 | 2.7 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.2 | 3.7 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.2 | 2.9 | GO:0051084 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
0.2 | 3.5 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.2 | 1.7 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.2 | 0.6 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.2 | 0.5 | GO:0048211 | Golgi vesicle docking(GO:0048211) |
0.2 | 1.1 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.2 | 1.2 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.2 | 0.8 | GO:0051775 | response to redox state(GO:0051775) |
0.2 | 0.5 | GO:0002455 | humoral immune response mediated by circulating immunoglobulin(GO:0002455) |
0.2 | 0.6 | GO:0060353 | regulation of cell adhesion molecule production(GO:0060353) positive regulation of cell adhesion molecule production(GO:0060355) |
0.1 | 1.9 | GO:0031498 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.1 | 4.1 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.1 | 3.2 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.1 | 3.9 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.1 | 1.7 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.1 | 4.7 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.1 | 3.5 | GO:0045739 | positive regulation of DNA repair(GO:0045739) |
0.1 | 3.9 | GO:0030514 | negative regulation of BMP signaling pathway(GO:0030514) |
0.1 | 1.8 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.1 | 2.5 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.1 | 0.9 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
0.1 | 2.1 | GO:0006767 | water-soluble vitamin metabolic process(GO:0006767) |
0.1 | 1.6 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 3.7 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
0.1 | 2.3 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.1 | 1.0 | GO:0009109 | coenzyme catabolic process(GO:0009109) cofactor catabolic process(GO:0051187) |
0.1 | 0.7 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 2.0 | GO:0002377 | immunoglobulin production(GO:0002377) |
0.1 | 4.1 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.1 | 12.0 | GO:0051028 | mRNA transport(GO:0051028) |
0.1 | 0.9 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 1.5 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.1 | 2.7 | GO:0003341 | cilium movement(GO:0003341) |
0.1 | 0.7 | GO:0031643 | positive regulation of myelination(GO:0031643) |
0.1 | 2.1 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.1 | 2.4 | GO:0006284 | base-excision repair(GO:0006284) |
0.1 | 2.7 | GO:0006940 | regulation of smooth muscle contraction(GO:0006940) |
0.1 | 0.8 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.1 | 0.4 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.1 | 1.5 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.1 | 1.3 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.1 | 3.9 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.1 | 0.9 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.1 | 4.0 | GO:0003073 | regulation of systemic arterial blood pressure(GO:0003073) |
0.1 | 1.2 | GO:0071353 | response to interleukin-4(GO:0070670) cellular response to interleukin-4(GO:0071353) |
0.1 | 2.8 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.1 | 1.6 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.5 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.1 | 0.4 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.1 | 0.5 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.1 | 0.8 | GO:0001947 | heart looping(GO:0001947) |
0.1 | 0.5 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.1 | 0.2 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.1 | 0.3 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.1 | 2.8 | GO:0007498 | mesoderm development(GO:0007498) |
0.1 | 1.9 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.1 | GO:0010829 | negative regulation of glucose transport(GO:0010829) negative regulation of glucose import(GO:0046325) |
0.1 | 0.7 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
0.1 | 0.9 | GO:0007398 | ectoderm development(GO:0007398) |
0.1 | 0.5 | GO:0015838 | amino-acid betaine transport(GO:0015838) carnitine transport(GO:0015879) |
0.1 | 2.8 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.1 | 2.2 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.1 | 0.5 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.1 | 3.0 | GO:0001959 | regulation of cytokine-mediated signaling pathway(GO:0001959) |
0.1 | 0.3 | GO:1902224 | cellular ketone body metabolic process(GO:0046950) ketone body metabolic process(GO:1902224) |
0.1 | 2.1 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.1 | 1.1 | GO:0010388 | protein deneddylation(GO:0000338) cullin deneddylation(GO:0010388) |
0.1 | 1.3 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.1 | 0.9 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 1.6 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.1 | 1.1 | GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process(GO:2000060) |
0.1 | 0.9 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 2.3 | GO:0043524 | negative regulation of neuron apoptotic process(GO:0043524) |
0.1 | 0.5 | GO:0021987 | cerebral cortex development(GO:0021987) |
0.1 | 0.5 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.1 | 0.9 | GO:0009303 | rRNA transcription(GO:0009303) |
0.1 | 2.2 | GO:0000725 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.1 | 2.7 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) |
0.1 | 1.4 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
0.1 | 0.2 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.1 | 1.5 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
0.1 | 2.9 | GO:0001837 | epithelial to mesenchymal transition(GO:0001837) |
0.1 | 1.5 | GO:1903305 | regulation of regulated secretory pathway(GO:1903305) |
0.0 | 0.1 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.0 | 0.3 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.0 | 3.2 | GO:1903214 | regulation of protein targeting to mitochondrion(GO:1903214) |
0.0 | 0.7 | GO:0035058 | nonmotile primary cilium assembly(GO:0035058) |
0.0 | 10.9 | GO:0008380 | RNA splicing(GO:0008380) |
0.0 | 0.1 | GO:0015886 | heme transport(GO:0015886) |
0.0 | 0.1 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.0 | 0.7 | GO:0032091 | negative regulation of protein binding(GO:0032091) |
0.0 | 0.2 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.0 | 0.1 | GO:0042117 | monocyte activation(GO:0042117) |
0.0 | 0.5 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.0 | 0.2 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.0 | 0.1 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
0.0 | 0.4 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.0 | 0.3 | GO:0006303 | non-recombinational repair(GO:0000726) double-strand break repair via nonhomologous end joining(GO:0006303) |
0.0 | 0.2 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.0 | 0.2 | GO:0060563 | neuroepithelial cell differentiation(GO:0060563) |
0.0 | 0.3 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.0 | 0.6 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.0 | 2.8 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.0 | 0.1 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.0 | 0.1 | GO:0051496 | positive regulation of actin filament bundle assembly(GO:0032233) positive regulation of stress fiber assembly(GO:0051496) |
0.0 | 0.1 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.0 | 0.3 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.0 | 0.5 | GO:0007179 | transforming growth factor beta receptor signaling pathway(GO:0007179) |
0.0 | 0.1 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.0 | 0.3 | GO:0035904 | aorta development(GO:0035904) |
Gene overrepresentation in cellular_component category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
7.8 | 38.9 | GO:0097149 | centralspindlin complex(GO:0097149) |
6.0 | 47.7 | GO:0005833 | hemoglobin complex(GO:0005833) |
4.2 | 38.0 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) |
4.1 | 62.2 | GO:0042555 | MCM complex(GO:0042555) |
3.9 | 11.7 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
3.5 | 10.6 | GO:0005588 | collagen type V trimer(GO:0005588) |
3.1 | 18.7 | GO:0001674 | female germ cell nucleus(GO:0001674) |
3.1 | 18.4 | GO:0031262 | Ndc80 complex(GO:0031262) |
3.0 | 6.0 | GO:0043657 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
3.0 | 8.9 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
2.7 | 13.5 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
2.4 | 7.2 | GO:0036387 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
2.2 | 11.1 | GO:0008623 | CHRAC(GO:0008623) |
2.0 | 4.1 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
2.0 | 6.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
2.0 | 91.9 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
1.8 | 11.0 | GO:0000796 | condensin complex(GO:0000796) |
1.8 | 16.2 | GO:0030478 | actin cap(GO:0030478) |
1.8 | 7.1 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
1.7 | 17.2 | GO:0001939 | female pronucleus(GO:0001939) |
1.7 | 6.8 | GO:0032133 | chromosome passenger complex(GO:0032133) |
1.4 | 5.5 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
1.4 | 2.7 | GO:0001739 | sex chromatin(GO:0001739) |
1.3 | 6.7 | GO:0070187 | telosome(GO:0070187) |
1.3 | 6.5 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
1.3 | 3.8 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
1.2 | 11.9 | GO:0070531 | BRCA1-A complex(GO:0070531) |
1.2 | 7.0 | GO:0030870 | Mre11 complex(GO:0030870) |
1.1 | 4.5 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
1.1 | 9.1 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
1.1 | 4.5 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
1.1 | 4.3 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
1.0 | 3.1 | GO:0005673 | transcription factor TFIIE complex(GO:0005673) |
1.0 | 7.0 | GO:0042613 | MHC class II protein complex(GO:0042613) |
1.0 | 7.0 | GO:0060293 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
1.0 | 9.0 | GO:0061617 | MICOS complex(GO:0061617) |
1.0 | 4.0 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
0.9 | 3.7 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.9 | 7.1 | GO:0070652 | HAUS complex(GO:0070652) |
0.8 | 5.1 | GO:0000235 | astral microtubule(GO:0000235) |
0.8 | 4.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.8 | 6.6 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.8 | 11.8 | GO:0043196 | varicosity(GO:0043196) |
0.8 | 7.7 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.7 | 3.0 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.7 | 13.3 | GO:0030894 | replisome(GO:0030894) |
0.7 | 4.4 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.7 | 3.7 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.7 | 4.4 | GO:0033010 | paranodal junction(GO:0033010) |
0.7 | 11.4 | GO:0033655 | host cell cytoplasm(GO:0030430) host cell cytoplasm part(GO:0033655) |
0.7 | 6.1 | GO:0000778 | condensed nuclear chromosome kinetochore(GO:0000778) |
0.7 | 3.3 | GO:0000798 | nuclear cohesin complex(GO:0000798) nuclear meiotic cohesin complex(GO:0034991) |
0.6 | 5.2 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.6 | 4.5 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.6 | 6.3 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.6 | 10.9 | GO:0035102 | PRC1 complex(GO:0035102) |
0.6 | 48.9 | GO:0005902 | microvillus(GO:0005902) |
0.6 | 4.1 | GO:0044295 | axonal growth cone(GO:0044295) |
0.6 | 7.7 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.6 | 1.8 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.6 | 4.1 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.6 | 3.9 | GO:0031527 | filopodium membrane(GO:0031527) |
0.6 | 4.5 | GO:0033269 | internode region of axon(GO:0033269) |
0.6 | 19.9 | GO:0043034 | costamere(GO:0043034) |
0.5 | 4.7 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.5 | 5.1 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.5 | 7.6 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.5 | 2.0 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.5 | 6.4 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.5 | 27.6 | GO:0005871 | kinesin complex(GO:0005871) |
0.5 | 6.0 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.5 | 0.5 | GO:0042571 | immunoglobulin complex, circulating(GO:0042571) |
0.5 | 5.0 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.5 | 3.2 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.4 | 1.8 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.4 | 1.3 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.4 | 1.3 | GO:0097233 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
0.4 | 6.5 | GO:0032156 | septin cytoskeleton(GO:0032156) |
0.4 | 4.7 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.4 | 1.7 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.4 | 32.1 | GO:0072562 | blood microparticle(GO:0072562) |
0.4 | 6.4 | GO:0036038 | MKS complex(GO:0036038) |
0.4 | 2.4 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.4 | 1.6 | GO:0030904 | retromer complex(GO:0030904) |
0.4 | 2.2 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.4 | 19.0 | GO:0016459 | myosin complex(GO:0016459) |
0.4 | 4.7 | GO:0031209 | SCAR complex(GO:0031209) |
0.4 | 4.3 | GO:0016589 | NURF complex(GO:0016589) |
0.4 | 3.9 | GO:0046930 | pore complex(GO:0046930) |
0.4 | 1.8 | GO:0005861 | troponin complex(GO:0005861) |
0.4 | 1.8 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.3 | 4.2 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.3 | 4.8 | GO:0042611 | MHC protein complex(GO:0042611) |
0.3 | 1.4 | GO:0035339 | SPOTS complex(GO:0035339) |
0.3 | 3.7 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.3 | 3.6 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.3 | 1.3 | GO:0061702 | inflammasome complex(GO:0061702) |
0.3 | 62.1 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.3 | 2.5 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.3 | 4.0 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.3 | 0.9 | GO:1990393 | 3M complex(GO:1990393) |
0.3 | 4.2 | GO:0016580 | Sin3 complex(GO:0016580) |
0.3 | 2.7 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.3 | 28.9 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.3 | 9.5 | GO:0005876 | spindle microtubule(GO:0005876) |
0.3 | 2.9 | GO:0005642 | annulate lamellae(GO:0005642) |
0.3 | 0.6 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.3 | 5.1 | GO:0005605 | basal lamina(GO:0005605) |
0.3 | 3.9 | GO:0005614 | interstitial matrix(GO:0005614) |
0.3 | 24.2 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.3 | 4.9 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.3 | 7.5 | GO:0045121 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.3 | 2.3 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.3 | 22.2 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.3 | 2.0 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.3 | 3.1 | GO:0031512 | motile primary cilium(GO:0031512) |
0.3 | 26.3 | GO:0031513 | nonmotile primary cilium(GO:0031513) |
0.3 | 2.0 | GO:0014704 | intercalated disc(GO:0014704) |
0.3 | 95.2 | GO:0005667 | transcription factor complex(GO:0005667) |
0.2 | 0.5 | GO:0070552 | BRISC complex(GO:0070552) |
0.2 | 28.4 | GO:0000776 | kinetochore(GO:0000776) |
0.2 | 4.2 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.2 | 2.7 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.2 | 3.9 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.2 | 1.5 | GO:0097427 | microtubule bundle(GO:0097427) |
0.2 | 2.4 | GO:0070419 | nonhomologous end joining complex(GO:0070419) |
0.2 | 14.7 | GO:0030118 | clathrin coat(GO:0030118) |
0.2 | 5.6 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.2 | 9.1 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.2 | 0.5 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.2 | 3.6 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.2 | 2.5 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.2 | 3.1 | GO:0005922 | connexon complex(GO:0005922) |
0.2 | 1.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.2 | 1.7 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.2 | 1.5 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) |
0.2 | 4.6 | GO:0001741 | XY body(GO:0001741) |
0.2 | 2.1 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.2 | 3.9 | GO:0002102 | podosome(GO:0002102) |
0.2 | 2.4 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.2 | 1.2 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.2 | 3.5 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.2 | 1.1 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
0.2 | 2.8 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.2 | 24.6 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.2 | 7.1 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.2 | 0.8 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.2 | 2.3 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 6.8 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 1.4 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.1 | 2.7 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 6.1 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 1.6 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.1 | 14.8 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 0.8 | GO:0097342 | ripoptosome(GO:0097342) |
0.1 | 0.1 | GO:0070876 | SOSS complex(GO:0070876) |
0.1 | 4.8 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.1 | 1.7 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 1.0 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 1.6 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.1 | 4.8 | GO:0005844 | polysome(GO:0005844) |
0.1 | 0.7 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 1.5 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 1.0 | GO:0000346 | transcription export complex(GO:0000346) |
0.1 | 6.5 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.1 | 0.5 | GO:0090543 | Flemming body(GO:0090543) |
0.1 | 7.2 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 0.4 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 2.3 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.1 | 31.8 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.1 | 0.4 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 1.3 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 0.5 | GO:0034709 | methylosome(GO:0034709) |
0.1 | 1.7 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 3.2 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.1 | 2.9 | GO:0030684 | preribosome(GO:0030684) |
0.1 | 0.9 | GO:0022626 | cytosolic ribosome(GO:0022626) |
0.1 | 2.9 | GO:0034707 | chloride channel complex(GO:0034707) |
0.1 | 5.2 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 20.9 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 0.4 | GO:0036157 | outer dynein arm(GO:0036157) |
0.1 | 1.3 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.1 | 1.0 | GO:0030119 | AP-type membrane coat adaptor complex(GO:0030119) |
0.1 | 4.6 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.1 | 2.6 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.1 | 1.2 | GO:0031514 | motile cilium(GO:0031514) |
0.1 | 0.7 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 0.8 | GO:0031902 | late endosome membrane(GO:0031902) |
0.1 | 0.1 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.1 | 6.1 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.1 | 5.2 | GO:0005840 | ribosome(GO:0005840) |
0.1 | 0.5 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 2.5 | GO:0005882 | intermediate filament(GO:0005882) |
0.1 | 0.9 | GO:0035770 | ribonucleoprotein granule(GO:0035770) |
0.1 | 0.3 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 5.8 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.1 | 1.2 | GO:0005581 | collagen trimer(GO:0005581) |
0.1 | 1.6 | GO:0005770 | late endosome(GO:0005770) |
0.1 | 8.4 | GO:0043235 | receptor complex(GO:0043235) |
0.1 | 1.3 | GO:0001772 | immunological synapse(GO:0001772) |
0.1 | 0.7 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 13.3 | GO:0030055 | cell-substrate junction(GO:0030055) |
0.0 | 0.3 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 6.4 | GO:0043197 | dendritic spine(GO:0043197) |
0.0 | 0.3 | GO:0051233 | spindle midzone(GO:0051233) |
0.0 | 0.2 | GO:0044447 | axoneme part(GO:0044447) |
0.0 | 5.6 | GO:0031965 | nuclear membrane(GO:0031965) |
0.0 | 1.3 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.0 | 1.5 | GO:0000922 | spindle pole(GO:0000922) |
0.0 | 0.3 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 1.4 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 138.7 | GO:0005634 | nucleus(GO:0005634) |
0.0 | 1.1 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 0.1 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.0 | 0.2 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.0 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.5 | GO:0005923 | bicellular tight junction(GO:0005923) |
Gene overrepresentation in molecular_function category:
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.0 | 50.2 | GO:0005344 | oxygen transporter activity(GO:0005344) |
7.1 | 21.3 | GO:0000402 | open form four-way junction DNA binding(GO:0000401) crossed form four-way junction DNA binding(GO:0000402) |
4.0 | 16.2 | GO:0038049 | glucocorticoid receptor activity(GO:0004883) transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
3.6 | 14.5 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
3.4 | 17.0 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
3.1 | 12.3 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) D-glucose transmembrane transporter activity(GO:0055056) |
2.8 | 8.4 | GO:0005118 | sevenless binding(GO:0005118) |
2.7 | 8.2 | GO:0052740 | phosphatidylserine 1-acylhydrolase activity(GO:0052739) 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
2.6 | 10.4 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
2.4 | 29.3 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
2.4 | 7.3 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
2.4 | 7.2 | GO:0019966 | C-X-C chemokine binding(GO:0019958) interleukin-1 binding(GO:0019966) tumor necrosis factor binding(GO:0043120) |
2.3 | 7.0 | GO:0004454 | ketohexokinase activity(GO:0004454) |
2.3 | 9.2 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
2.3 | 6.9 | GO:0008502 | melatonin receptor activity(GO:0008502) |
2.3 | 11.4 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
2.2 | 57.0 | GO:0008432 | JUN kinase binding(GO:0008432) |
2.1 | 10.5 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
2.1 | 22.7 | GO:0008517 | folic acid transporter activity(GO:0008517) |
2.0 | 4.1 | GO:0000405 | bubble DNA binding(GO:0000405) |
2.0 | 6.1 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
2.0 | 7.9 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
2.0 | 7.9 | GO:0097003 | adipokinetic hormone receptor activity(GO:0097003) |
1.8 | 27.4 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
1.8 | 7.3 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
1.8 | 1.8 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
1.7 | 5.1 | GO:0035575 | histone demethylase activity (H4-K20 specific)(GO:0035575) |
1.7 | 5.0 | GO:0004568 | chitinase activity(GO:0004568) |
1.6 | 13.0 | GO:0050693 | LBD domain binding(GO:0050693) |
1.6 | 6.3 | GO:0043515 | kinetochore binding(GO:0043515) |
1.5 | 7.7 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
1.5 | 4.5 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
1.5 | 1.5 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
1.5 | 68.6 | GO:0097472 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
1.5 | 4.5 | GO:0009881 | photoreceptor activity(GO:0009881) |
1.5 | 1.5 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
1.4 | 14.5 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
1.4 | 11.3 | GO:0003688 | DNA replication origin binding(GO:0003688) |
1.4 | 4.2 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
1.4 | 21.6 | GO:0035198 | miRNA binding(GO:0035198) |
1.3 | 5.4 | GO:0008142 | oxysterol binding(GO:0008142) |
1.3 | 37.7 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
1.3 | 17.0 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
1.3 | 66.1 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
1.3 | 9.1 | GO:0016918 | retinal binding(GO:0016918) |
1.3 | 5.2 | GO:0036468 | aromatic-L-amino-acid decarboxylase activity(GO:0004058) L-dopa decarboxylase activity(GO:0036468) |
1.3 | 9.0 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
1.3 | 5.0 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
1.2 | 30.0 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
1.2 | 19.6 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
1.2 | 4.8 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
1.2 | 3.6 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
1.2 | 15.3 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
1.1 | 3.4 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
1.1 | 4.6 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
1.1 | 11.3 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
1.1 | 3.4 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
1.1 | 4.3 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
1.1 | 16.0 | GO:0005537 | mannose binding(GO:0005537) |
1.1 | 26.5 | GO:0030506 | ankyrin binding(GO:0030506) |
1.1 | 3.2 | GO:0016015 | morphogen activity(GO:0016015) |
1.0 | 4.1 | GO:0004954 | icosanoid receptor activity(GO:0004953) prostanoid receptor activity(GO:0004954) prostaglandin receptor activity(GO:0004955) |
1.0 | 3.0 | GO:0043912 | D-lysine oxidase activity(GO:0043912) |
1.0 | 3.0 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
1.0 | 21.9 | GO:0017049 | GTP-Rho binding(GO:0017049) |
1.0 | 3.9 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
1.0 | 3.9 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.9 | 8.5 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.9 | 11.3 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.9 | 5.6 | GO:0052630 | CTP:2,3-di-O-geranylgeranyl-sn-glycero-1-phosphate cytidyltransferase activity(GO:0043338) phospholactate guanylyltransferase activity(GO:0043814) ATP:coenzyme F420 adenylyltransferase activity(GO:0043910) UDP-N-acetylgalactosamine diphosphorylase activity(GO:0052630) |
0.9 | 15.8 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.9 | 11.0 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.9 | 3.6 | GO:0004104 | cholinesterase activity(GO:0004104) choline binding(GO:0033265) |
0.9 | 4.5 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.9 | 8.0 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.9 | 7.9 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.9 | 6.9 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.9 | 2.6 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.9 | 12.8 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
0.8 | 9.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.8 | 8.4 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.8 | 5.0 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) lysophosphatidic acid receptor activity(GO:0070915) |
0.8 | 9.1 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.8 | 2.5 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.8 | 4.1 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.8 | 3.3 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.8 | 2.4 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
0.8 | 9.7 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.8 | 3.2 | GO:0004921 | interleukin-11 receptor activity(GO:0004921) interleukin-11 binding(GO:0019970) |
0.8 | 1.6 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.8 | 3.2 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.8 | 11.8 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.8 | 7.8 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.8 | 4.6 | GO:0043426 | MRF binding(GO:0043426) |
0.7 | 6.7 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.7 | 6.7 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.7 | 3.7 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.7 | 3.0 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.7 | 11.0 | GO:0008430 | selenium binding(GO:0008430) |
0.7 | 2.2 | GO:0070905 | serine binding(GO:0070905) |
0.7 | 5.1 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.7 | 4.4 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.7 | 2.2 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.7 | 2.2 | GO:0032052 | bile acid binding(GO:0032052) |
0.7 | 2.1 | GO:0019956 | chemokine binding(GO:0019956) |
0.7 | 3.6 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.7 | 6.4 | GO:0015643 | toxic substance binding(GO:0015643) |
0.7 | 3.5 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.7 | 3.5 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
0.7 | 2.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.7 | 2.7 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.7 | 2.7 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.7 | 6.0 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.7 | 2.0 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.7 | 2.7 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
0.7 | 2.0 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.6 | 5.8 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.6 | 3.9 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.6 | 11.4 | GO:0008266 | poly(U) RNA binding(GO:0008266) |
0.6 | 12.6 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
0.6 | 9.2 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.6 | 4.3 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.6 | 1.8 | GO:0071568 | UFM1 transferase activity(GO:0071568) |
0.6 | 112.3 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
0.6 | 1.8 | GO:0004145 | diamine N-acetyltransferase activity(GO:0004145) |
0.6 | 1.8 | GO:0030172 | troponin C binding(GO:0030172) |
0.6 | 10.1 | GO:0070402 | NADPH binding(GO:0070402) |
0.6 | 4.1 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.6 | 1.8 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
0.6 | 1.8 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.6 | 5.3 | GO:0031698 | beta-2 adrenergic receptor binding(GO:0031698) |
0.6 | 1.8 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.6 | 1.7 | GO:0086038 | calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential(GO:0086038) |
0.6 | 1.7 | GO:0003680 | AT DNA binding(GO:0003680) |
0.5 | 3.2 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.5 | 11.6 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.5 | 1.6 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
0.5 | 3.6 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.5 | 1.5 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.5 | 14.3 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.5 | 2.5 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.5 | 2.5 | GO:0008392 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.5 | 2.5 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.5 | 3.0 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.5 | 2.5 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
0.5 | 4.9 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.5 | 13.3 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.5 | 0.9 | GO:0070052 | collagen V binding(GO:0070052) |
0.5 | 21.0 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.5 | 7.0 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.5 | 6.4 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.5 | 4.5 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.4 | 1.3 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.4 | 9.6 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.4 | 3.5 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.4 | 6.0 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.4 | 2.1 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.4 | 3.4 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.4 | 16.4 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.4 | 1.3 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.4 | 1.3 | GO:0045182 | translation regulator activity(GO:0045182) |
0.4 | 1.6 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.4 | 2.5 | GO:0050815 | phosphoserine binding(GO:0050815) |
0.4 | 2.0 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.4 | 3.6 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.4 | 1.2 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
0.4 | 6.0 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.4 | 3.2 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.4 | 17.5 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.4 | 3.9 | GO:0051400 | BH domain binding(GO:0051400) |
0.4 | 1.6 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.4 | 4.6 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.4 | 7.2 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.4 | 8.7 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.4 | 1.1 | GO:0004096 | catalase activity(GO:0004096) |
0.4 | 2.6 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.4 | 2.5 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.4 | 2.9 | GO:0030274 | LIM domain binding(GO:0030274) |
0.4 | 1.1 | GO:0071633 | dihydroceramidase activity(GO:0071633) |
0.4 | 2.9 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.4 | 1.4 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.4 | 6.0 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.3 | 2.1 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.3 | 3.8 | GO:0008143 | poly(A) binding(GO:0008143) |
0.3 | 1.0 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.3 | 30.3 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.3 | 13.6 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.3 | 8.7 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.3 | 33.0 | GO:0005178 | integrin binding(GO:0005178) |
0.3 | 5.6 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.3 | 14.1 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.3 | 9.2 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.3 | 1.6 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.3 | 2.6 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.3 | 8.3 | GO:0008235 | metalloexopeptidase activity(GO:0008235) |
0.3 | 3.8 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.3 | 5.0 | GO:0016594 | glycine binding(GO:0016594) |
0.3 | 2.8 | GO:0017166 | vinculin binding(GO:0017166) |
0.3 | 1.9 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.3 | 5.2 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.3 | 1.5 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.3 | 3.3 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.3 | 43.7 | GO:0051015 | actin filament binding(GO:0051015) |
0.3 | 0.9 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
0.3 | 1.2 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
0.3 | 14.9 | GO:0035064 | methylated histone binding(GO:0035064) |
0.3 | 2.0 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.3 | 3.4 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.3 | 1.1 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.3 | 19.8 | GO:0008186 | ATP-dependent RNA helicase activity(GO:0004004) RNA-dependent ATPase activity(GO:0008186) |
0.3 | 1.7 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.3 | 1.4 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.3 | 1.4 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.3 | 5.6 | GO:0030332 | cyclin binding(GO:0030332) |
0.3 | 7.5 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.3 | 1.1 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.3 | 7.1 | GO:0005112 | Notch binding(GO:0005112) |
0.3 | 3.9 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.3 | 1.8 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.3 | 1.8 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.2 | 0.5 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.2 | 1.0 | GO:0004092 | carnitine O-acetyltransferase activity(GO:0004092) |
0.2 | 1.5 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.2 | 0.7 | GO:0043758 | acetate-CoA ligase (ADP-forming) activity(GO:0043758) |
0.2 | 4.9 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.2 | 1.0 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.2 | 3.3 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.2 | 0.7 | GO:0046997 | sarcosine dehydrogenase activity(GO:0008480) oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
0.2 | 2.5 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.2 | 3.4 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.2 | 2.0 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.2 | 3.8 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 1.3 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.2 | 1.3 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.2 | 4.5 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
0.2 | 8.4 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.2 | 1.2 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.2 | 4.6 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.2 | 1.8 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.2 | 1.2 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.2 | 3.1 | GO:0031404 | voltage-gated chloride channel activity(GO:0005247) chloride ion binding(GO:0031404) |
0.2 | 5.4 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.2 | 2.6 | GO:0005123 | death receptor binding(GO:0005123) |
0.2 | 1.7 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.2 | 0.6 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.2 | 11.6 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.2 | 13.9 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.2 | 4.9 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.2 | 0.9 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.2 | 7.1 | GO:0019894 | kinesin binding(GO:0019894) |
0.2 | 1.6 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.2 | 0.5 | GO:0005124 | scavenger receptor binding(GO:0005124) |
0.2 | 6.6 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.2 | 2.3 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.2 | 3.1 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
0.2 | 0.9 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.2 | 1.4 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.2 | 3.3 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.2 | 2.1 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.2 | 1.0 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.2 | 1.2 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.2 | 0.8 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.2 | 9.4 | GO:0002039 | p53 binding(GO:0002039) |
0.2 | 1.0 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.2 | 1.2 | GO:0034946 | 2-oxoglutaryl-CoA thioesterase activity(GO:0034843) 2,4,4-trimethyl-3-oxopentanoyl-CoA thioesterase activity(GO:0034869) 3-isopropylbut-3-enoyl-CoA thioesterase activity(GO:0034946) glutaryl-CoA hydrolase activity(GO:0044466) |
0.2 | 0.5 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.2 | 0.9 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.2 | 0.6 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
0.1 | 3.7 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.1 | 0.1 | GO:0016934 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.1 | 5.2 | GO:0045502 | dynein binding(GO:0045502) |
0.1 | 1.0 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.1 | 0.4 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.1 | 0.4 | GO:0017040 | ceramidase activity(GO:0017040) |
0.1 | 1.0 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 5.0 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 0.4 | GO:0070513 | death domain binding(GO:0070513) |
0.1 | 1.7 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 3.4 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.1 | 7.2 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 1.8 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.1 | 1.4 | GO:0015026 | coreceptor activity(GO:0015026) |
0.1 | 1.5 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 2.9 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.5 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
0.1 | 2.3 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 4.3 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 0.5 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.1 | 5.1 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.1 | 1.0 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 5.0 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 1.4 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.1 | 7.7 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.1 | 6.1 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 0.6 | GO:0019145 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.1 | 0.5 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.1 | 4.5 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.1 | 3.7 | GO:0031491 | nucleosome binding(GO:0031491) |
0.1 | 4.2 | GO:0044824 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.1 | 1.5 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 4.2 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.1 | 0.6 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.1 | 2.5 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.1 | 1.6 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 0.7 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.1 | 12.5 | GO:0008022 | protein C-terminus binding(GO:0008022) |
0.1 | 0.1 | GO:0048256 | 5'-flap endonuclease activity(GO:0017108) flap endonuclease activity(GO:0048256) |
0.1 | 2.2 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.1 | 1.1 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 0.3 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 0.6 | GO:0050692 | DBD domain binding(GO:0050692) |
0.1 | 0.3 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.1 | 8.1 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.1 | 16.6 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 4.2 | GO:0046332 | SMAD binding(GO:0046332) |
0.1 | 2.0 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 2.2 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 1.3 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.3 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 0.6 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.9 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.1 | 0.3 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.1 | 0.5 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
0.1 | 0.5 | GO:0045703 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.1 | 0.7 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.1 | 1.0 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.1 | 0.4 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.1 | 2.1 | GO:0020037 | heme binding(GO:0020037) |
0.1 | 17.5 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 1.7 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.0 | 0.4 | GO:1990446 | U1 snRNP binding(GO:1990446) |
0.0 | 0.1 | GO:0015232 | heme transporter activity(GO:0015232) |
0.0 | 1.5 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.5 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.9 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 1.8 | GO:0035254 | glutamate receptor binding(GO:0035254) |
0.0 | 0.7 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.0 | 1.3 | GO:0005518 | collagen binding(GO:0005518) |
0.0 | 0.4 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.0 | 0.8 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.4 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.0 | 0.1 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
0.0 | 1.5 | GO:0051287 | NAD binding(GO:0051287) |
0.0 | 1.9 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.0 | 0.5 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.0 | 0.8 | GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds(GO:0004553) |
0.0 | 0.7 | GO:0001104 | RNA polymerase II transcription cofactor activity(GO:0001104) |
0.0 | 1.9 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.0 | 0.6 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.4 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.0 | 0.3 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 0.6 | GO:0008013 | beta-catenin binding(GO:0008013) |
0.0 | 0.5 | GO:0003774 | motor activity(GO:0003774) |
0.0 | 0.2 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.0 | 0.2 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.3 | GO:0017069 | snRNA binding(GO:0017069) |
0.0 | 0.6 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.0 | 0.2 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
0.0 | 0.3 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.0 | 0.1 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 20.3 | GO:0003677 | DNA binding(GO:0003677) |
0.0 | 0.4 | GO:0002020 | protease binding(GO:0002020) |
0.0 | 0.2 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.0 | 0.3 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |